Clin2
NCT07728383Possibly a fitRecruiting

Obesity treatment study using tongue-applied semaglutide

Obesity & Overweight

Treatments studied

Part of Hormones & metabolism clinical trials.

This trial tests a new way to deliver semaglutide through a strip placed on the tongue for weight loss in adults with obesity. It may help you lose weight without a needle.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
40 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • Your body mass index (BMI) is between 30 and 45
  • You do not have type 2 diabetes
  • You do not have a rare thyroid condition called medullary thyroid cancer or multiple endocrine neoplasia type 2

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07430059Not yet recruiting· Phase 1
Study of a semaglutide implant for weight management

This early-stage study tests a small implant placed under the skin that releases a weight management medicine (semaglutide) slowly over time. The goal is to see how safe it is and how your body handles it.

NCT07411378Not yet recruiting· Phase 2
Study of a plant extract with semaglutide for weight loss

This trial tests whether adding a plant-based supplement (called 20E) to the weight-loss medication semaglutide can improve weight loss and muscle health. You would take the supplement as capsules alongside your regular semaglutide treatment.

NCT07622810Not yet recruiting· Phase 3
Weight loss injection compared to a standard treatment

This study tests a new injection called bofanglutide to see if it helps people with overweight or obesity lose more weight than a standard treatment. It is for adults who have not been able to lose weight with diet and exercise alone.

Guadalajara, Jalisco
NCT07870538Recruiting· Phase 4
Matching weight-loss treatments to binge eating patterns

This study tests whether a medication called semaglutide, which is used for weight loss, works better for people who also have binge eating. It aims to find the best treatment based on brain and behavior differences.

Leuven
NCT07423481Not yet recruiting
Weight changes after semaglutide in severe obesity

This study looks at how weight changes over time in people with severe or complicated obesity who have already started taking the medication semaglutide (brand name Wegovy). It aims to find factors that predict who will lose the most weight.

Nantes
NCT06633783Not yet recruiting· Phase 3
Weekly shot for weight loss in adults with obesity

This study tests a weekly injection called semaglutide to see how well it helps people with obesity lose weight, compared to a similar approved medicine, Wegovy. It may be an option if you have struggled to lose weight in the past.

Xuancheng, Anhui

Hear when a new Obesity & Overweight trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.